SWEDISH ISSAQUAH — History
CCN 500152 | 3-year financial timeline | COVID resilience: 79/100
🛡️ Public data only — no PHI permitted on this instance.
$283M
Latest Revenue (FY2022)
+17.6%
Revenue CAGR (3yr)
-6.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $204M | $261M | $283M | +8.3% | +17.6% |
| Operating Expenses | $246M | $278M | $300M | +8.0% | +10.5% |
| Operating Margin | -20.2% | -6.5% | -6.1% | +5.6% | +0.0% |
| Net Income | $-41M | $-17M | $-17M | -2.3% | +0.0% |
| Licensed Beds | 166 | 163 | 157 | -3.7% | -2.7% |
| Total Patient Days | 22,979 | 26,172 | 29,708 | +13.5% | +13.7% |
| Medicare Day % | 30% | 25% | 24% | -1.3% | -10.2% |
| Medicaid Day % | 1% | 1% | 3% | +140.0% | +97.0% |
COVID Impact & Recovery
Resilience Score: 79/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +38.4% ($204M → $283M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+17.6%
This Hospital
+7.6%
State Avg
Latest Margin
-6.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $322M | 0.9% |
| FY2024 (proj) | $361M | 7.9% |
| FY2025 (proj) | $400M | 15.0% |